Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) is now available.
Shandong Xinhua Pharmaceutical Company Limited has announced that its board of directors will hold a meeting on March 28, 2025, to consider and approve the audited annual results for the year ending December 31, 2024. The meeting will also discuss the recommendation of a final dividend and address any other business matters. This announcement indicates the company’s ongoing commitment to transparency and shareholder engagement, potentially impacting its market positioning and stakeholder relations.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a joint stock company based in the People’s Republic of China, specializing in the pharmaceutical industry. The company is involved in the production and distribution of pharmaceutical products.
YTD Price Performance: -0.86%
Average Trading Volume: 3,321,745
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: HK$9.03B
See more data about 0719 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue